Inozyme Pharma, Inc. (INZY) Financials
Stock symbol INZY is outdated, potentially delisted? Maybe it is available on other exchange?
INZY Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2023 | 200.8 million | 60.4 million |
| Sept. 30, 2023 | 205.7 million | 45.5 million |
| June 30, 2023 | 150.9 million | 45.3 million |
| March 31, 2023 | 141.8 million | 38.4 million |
INZY Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2023 | -18.6 million | 1.7 million |
| Sept. 30, 2023 | -18.9 million | 1.7 million |
| June 30, 2023 | -15.6 million | 1.6 million |
| March 31, 2023 | -17.9 million | 2.1 million |
INZY Net Income
No data available :(
INZY Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2023 | 188.6 million | - | 1.8 million |
| Sept. 30, 2023 | 192.4 million | - | 2.0 million |
| June 30, 2023 | 140.2 million | 31.9 million | 2.2 million |
| March 31, 2023 | 130.9 million | 24.2 million | 2.4 million |
INZY Shares Outstanding
INZY Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2023 | 105000 | 17.8 million | 4.8 million | 130000 |
| Sept. 30, 2023 | 7000 | 13.3 million | 4.7 million | - |
| June 30, 2023 | 11000 | 11.7 million | 4.7 million | - |
| March 31, 2023 | 175000 | 11.9 million | 6.5 million | - |
INZY Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2023 | - | 306000 |
| Sept. 30, 2023 | - | 333000 |
| June 30, 2023 | - | 331000 |
| March 31, 2023 | - | 324000 |
INZY
Price: $4
52 week price:
Earnings Per Share: -1.68 USD
P/E Ratio: -2.38
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 94105
Market Capitalization: 258.2 million